Table 1. Somatic characteristics, biochemical indices and WBC and its specific subpopulations count in two study measurements (before and after training programme) for the entire group of women (n = 23).

Parameters	Assessment at baseline (term I)	Assessment at the end (term II)
Body mass (kg)	68.09 ± 9.60	68.70 ± 9.59
	67.2 (62.4–74.8)	66.6 (62.8–76.2)*
BMI (kg/m2)	26.22 ± 3.38	26.47 ± 3.31
	25.5 (23.3–28.7)	25.8 (23.6–28.9)**
Fat mass (kg)	27.11 ± 6.19	26.59 ± 6.11
	26.1 (22.7–31.0)	25.9 (21.8–30.6)*
Fat mass (%)	40.62 ± 4.63	39.98 ± 4.41
	40.3 (37.0–43.7)	40.8 (36.1–43.2)*
25(OH)D (ng/ml)	27.01 ± 11.27	27.28 ± 10.82
	25.9 (16.1–32.5)	27.3 (17.8–37.0)
Glucose (mmol/l)	5.21 ± 0.55	5.28 ± 0.55
	5.2 (4.8–5.6)	5.2 (4.8–5.7)
Insulin (µIU/ml)	15.28 ± 6.51	12.13 ± 6.30
	16.4 (9.5–21.3)	10.2 (7.7–17.1)**
HOMA-IR	3.56 ± 1.62	2.90 ± 1.63
	3.6 (2.2–5.0)	2.5 (1.5–4.3)*
TC (mg/dl)	209.78 ± 36.51	195.70 ± 41.76
	204 (189–240)	182 (167–223)*
TG (mg/dl)	101.0 ± 59.77	91.26 ± 48.43
	87 (64–121)	81 (59–108)*
HDL-C (mg/dl)	63.71 ± 12.32	62.67 ± 11.39
	64.0 (56.8–71.9)	63.3 (57–70)
LDL-C (mg/dl)	139.27 ± 39.76	138.87 ± 43.98
	128.8 (107.5–165.1)	130.3 (103.9–178.4)
WBC (109/l)	6.35 ± 1.37	5.42 ± 1.26
	6.3 (4.9–7.2)	5.3 (4.6–6.0)**
LYM (109/l)	2.1 ± 0.56	1.87 ± 0.40
	2.0 (1.7–2.4)	1.8 (1.5–2.3)**
MON (109/l)	0.45 ± 0.12	0.27 ± 0.07
	0.4 (0.4–0.5)	0.3 (0.2–0.3)**
GRA (109/l)	3.81 ± 1.12	3.27 ± 0.99
	3.7 (2.8–4.7)	3.1 (2.8–3.5)*

Notes.

Results are expressed as mean (SD); median (interquartile range).

An asterisk (*) indicate p < 0.054, two asterisks (**) indicate p < 0.01; significant differences between the first and second terms of the study.

BMI

body mass index

25(OH)D

25-hydroxyvitamin D

HOMA-IR

homeostatic model assessment of insulin resistance index

TC

total cholesterol

TG

triglycerides

HDL-C

high density lipoprotein cholesterol

LDL-C

low density lipoprotein cholesterol

WBC

white blood cells

LYM

lymphocytes

MON

monocytes

GRA

granulocytes